Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Change in Accured Expenses (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Change in Accured Expenses for 15 consecutive years, with $6.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 45.28% year-over-year to $6.8 million, compared with a TTM value of -$2.3 million through Dec 2025, down 123.81%, and an annual FY2025 reading of -$2.3 million, down 123.81% over the prior year.
  • Change in Accured Expenses was $6.8 million for Q4 2025 at Orthofix Medical, down from $12.7 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $12.7 million in Q3 2025 and bottomed at -$21.4 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $648400.0, with a median of $2.9 million recorded in 2021.
  • Peak annual rise in Change in Accured Expenses hit 2030.47% in 2021, while the deepest fall reached 479.07% in 2021.
  • Year by year, Change in Accured Expenses stood at $5.0 million in 2021, then increased by 4.71% to $5.2 million in 2022, then dropped by 21.34% to $4.1 million in 2023, then surged by 203.18% to $12.4 million in 2024, then tumbled by 45.28% to $6.8 million in 2025.
  • Business Quant data shows Change in Accured Expenses for OFIX at $6.8 million in Q4 2025, $12.7 million in Q3 2025, and -$378000.0 in Q2 2025.